Stockreport

Curis to Present at Upcoming 30th Annual SNO Meeting [Yahoo! Finance]

Curis, Inc.  (CRIS) 
Last curis, inc. earnings: 11/1 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.curis.com
PDF emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that Curis will report emavusertib and BTKi clinical data in Primary CNS Lymp [Read more]